Connection
Jeffrey Bennett to Tomography, Optical Coherence
This is a "connection" page, showing publications Jeffrey Bennett has written about Tomography, Optical Coherence.
|
|
Connection Strength |
|
 |
|
 |
|
1.141 |
|
|
|
-
Horton L, Bennett JL. Acute Management of Optic Neuritis: An Evolving Paradigm. J Neuroophthalmol. 2018 09; 38(3):358-367.
Score: 0.581
-
Bennett JL. Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis: Sprinting to the Finish. Neurology. 2023 09 05; 101(10):420-421.
Score: 0.204
-
Bennett JL, Grove NC, Johnson RK, Mizenko C, DuPont JC, Wagner BD, Lynch AM, Frohman TC, Shindler KS, Frohman EM. A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic Neuritis. J Neuroophthalmol. 2023 09 01; 43(3):323-329.
Score: 0.202
-
Marin AI, Zarubina AV, Bennett JL, Subramanian PS. Seropositive Neuromyelitis Optica Spectrum Disorder Presenting With Optic Nerve Sheath Enhancement and Optic Disc Edema Resembling Optic Nerve Sheath Meningioma. J Neuroophthalmol. 2024 Sep 01; 44(3):e350-e352.
Score: 0.050
-
Havla J, Pakeerathan T, Schwake C, Bennett JL, Kleiter I, Felipe-Ruci?n A, Joachim SC, Lotz-Havla AS, K?mpfel T, Krumbholz M, Wendel EM, Reindl M, Thiels C, L?cke T, Hellwig K, Gold R, Rostasy K, Ayzenberg I. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well? J Neuroinflammation. 2021 May 29; 18(1):121.
Score: 0.044
-
Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD. Sci China Life Sci. 2016 Dec; 59(12):1270-1281.
Score: 0.031
-
Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J. ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. J Neurol Sci. 2015 Apr 15; 351(1-2):174-178.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|